Talk about your daily plays, ideas and strategies that do not warrant an actual post. This is the place to request buy/sell advice from the community. Remember to keep it civil. Trade responsibly.
I was expecting SPRO stock to increase after Tebipenem Hbr(Utebzi) approval from FDA. It seemed to be a no-brainer on paper, GSK handles the marketing after approval and pays milestones and royalties to SPRO. I understand that SPRO quit their …
One thing I have learned with biotech is that the big move often starts before the actual data, not after. By the time the readout arrives, the market has usually already started sorting the names into buckets: ignored science project, …
Hey guys, if you missed it, DiDi Global settled $740M with investors over claims related to its 2021 IPO and regulatory issues. I just found out that late claims are still being considered. Quick recap: After DiDi went public in …
VisionWave has been one of the more interesting defense tech companies I've been following recently. The Meteor Aerospace transaction really caught my attention. A 51% controlling interest gives VWAV exposure to unmanned systems, electronic warfare and other advanced defense technologies. …
GLOO (Gloo Holdings) is a small faith based tech / church software company, currently under $3 after falling roughly 63% from its highs near $8 over the past six months. on july 10, three insiders filed form 4 buys on …
Data centers are one of the hottest sectors right now. AI training, cloud computing, edge infrastructure — everything is exploding, and demand is outstripping supply in a major way. While the big hyperscalers grab headlines, smart money is looking at …
I've posted about Jones a few times over the past year and it's all playing out. Here's an update: **New management took a broken company to profitability in 4 quarters. Break-even is $10M/quarter, they're doing $12M+, insiders are buying, and …
***BioLargo's newly formed subsidiary, BioLargo CPG, will bring to consumers the authentic, independently safety-tested CupriDyne® technology under its own brand following the marketing success of the original Pooph products that generated more than $125 million in pet-care sales while under …